Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Basilea Pharmaceutica AG (BPMUF) Return on Tangible Equity data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$346.45M |
|
$5.88M |
|
$30.66M |
|
$377.10M |
|
$52.53M |
|
$89.39M |
|
$119.15M |
|
$171.68M |
|
$205.42M |
|
$205.14M |
|
$205.42M |
|
12.40M |
|
| Cash Flow Statement Financials | |
$24.01M |
|
$-0.56M |
|
$-6.17M |
|
$205.40M |
|
$222.66M |
|
$17.26M |
|
$3.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|